Health and Healthcare
For Boston Scientific (BSX) Stent News Gets More Complex
Published:
Stent sales for Boston Scientific (BSX) and Johnson & Johnson (JNJ) have taken a big drop since research began to emerge that the products could cause heart problems. There have been several conflicting studies about whether bare metal stents or drug-coated stents work better. And, some surveys indicate that drugs work better than either.
A new article in the New England Journal of Medicine offers evidence that drug-coated stents offer the best results for many patients, according to MarketWatch. Drug-coated stent patients needed fewer repeat procedure after they were implanted, compared to bare metal stents. And, they did not appear to raise the risk of heart attack.
That would seem to bring the matter to a conclusion. At least based on this study. But, the researchers did not seem to trust their own results "The small absolute difference in mortality in favor of drug-eluting stents in our study warrants further investigation and should be confirmed or refuted through large, randomized clinical trials with long-term follow-up," the researchers added.
Anyone who is confused can raise his hand. The news certainly will do little to help BSX.
Douglas A. McIntyre
The #1 Thing to Do Before You Claim Social Security (Sponsor)
Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.
A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.
Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
